Arizona Tribune - Boulevard

NYSE - LSE

SCS	0.12%	16.14	$
CMSD	-0.17%	24.05	$
JRI	1.07%	13.08	$
RBGPF	1.65%	83.78	$
BCC	0.63%	80.81	$
BCE	1.43%	25.86	$
CMSC	0.21%	23.76	$
AZN	0.19%	92.77	$
RIO	-4.5%	91.03	$
BTI	0.76%	60.68	$
GSK	1.82%	51.6	$
NGG	0.23%	85.27	$
VOD	-0.41%	14.65	$
RELX	-1.03%	35.8	$
BP	-0.42%	37.88	$
RYCEF	-2.69%	16	$

Featured

Venezuelan interim president announces mass amnesty push

Venezuela's acting president announced on Friday a proposal for mass amnesty in the country, in her latest major reform since the US toppling of Nicolas Maduro just weeks ago.

Venezuelan interim president proposes mass amnesty law

Venezuela's acting president announced on Friday a push for mass amnesty in the country, in her latest major reform since the US toppling of Nicolas Maduro just weeks ago.

Last news

UN accuses Israel of West Bank 'apartheid'

The United Nations on Wednesday said decades-long discrimination and segregation of Palestinians by Israel in the West Bank were intensifying, and called on the country to end its "apartheid system".

Vietnamese caught in Japan's illegal worker crackdown

For a decade, Vietnamese worker Minh did tough jobs like sandblasting ships and welding steel, helping address rapidly ageing Japan's dire labour needs.

Obituary Notice: Peter Schlesinger, 19-Time Emmy Award-Winning Television Producer and Longtime KCOP-TV Program Director

LOS ANGELES, CA / ACCESS Newswire / January 7, 2026 / It is with great sadness that we announce the passing of Peter Schlesinger, a noted figure in the television industry who served as Program Director for KCOP-TV from 1971 to 2001 and as a multiple Emmy Award-winning Executive Producer for both national and local television programming. Peter passed away on December 5 in Calabasas.

Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of $9.00, representing significant upside from the Company's closing price of $4.44 on January 6, 2026.

A Suitcase Full of Stories: Bring Home More Than Just Memories - Take Home Culture Too

Saudia Turns Luggage into Cultural Storytelling with ‘Let It Fly' Initiative

TRNR Provides Shareholder Update on Sportstech Process & Operating Strategy

AUSTIN, TEXAS / ACCESS Newswire / January 7, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME brands, today announced that it has published a shareholder letter updating investors with respect to the Sportstech loan and acquisition process and providing additional context about its improved operating scale and near-term plans.

AMEEREX Enters Strategic Partnership With Patagonia Lithium (ASX: PL3), Gaining Exposure to Inferred and Indicated 551,000 tonnes of Lithium Carbonate Equivalent JORC-Validated Lithium Resource by WSP Australia

ATLANTA, GA / ACCESS Newswire / January 7, 2026 / AMEEREX Corporation ("Ameerex" or the "Company") today announced that it has entered into a strategic partnership with Patagonia Lithium Limited (ASX:PL3), working towards securing a material economic interest in a world-class lithium brine resource located in Argentina's Lithium Triangle, one of the most important lithium-producing regions globally.

EDGE Surgical Launches Universal Depth Gauge - A Breakthrough in Orthopedics

BURLINGTON, MA / ACCESS Newswire / January 7, 2026 / EDGE Surgical, Inc, the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced the launch of a Universal Depth Gauge compatible with all major orthopedic plating systems. With patent-pending dynamic calibration technology, the Ortho EDG® is the world's first depth gauge to work with every major plating system - a quantum leap forward in depth gauge technology.

Medical Care Technologies' Infinite Auctions to Offer Original Art by Iconic Artist Rob Prior Signed by Stan Lee, Chris Evans, Al Pacino & More

MESA, ARIZONA / ACCESS Newswire / January 7, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) is excited to announce that its subsidiary, Infinite Auctions, will host "The Legends Art Auction," an exclusive event showcasing a remarkable collection of original art pieces by renowned artist Rob Prior and others. This highly anticipated auction will feature:

Phase 1 Equity Announces it's First Practice Addition of The Year, Bringing on a Multi-Site Orthodontic Practice Located in Ohio

CHICAGO, IL / ACCESS Newswire / January 7, 2026 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Ohio to its growing network.

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced the start of GMP manufacturing of GEMINI and placebo. This manufacturing run will provide the Company with clinical drug supply for later stage clinical studies.

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial

Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products

Canadian Patent Enhances Market Exclusivity and Licensing PotentialExpands Global Intellectual Property Portfolio Supporting Long-Term Revenue Growth

Forte Group Confirms Effective Date of Corporate Name Change to VANTA, advancing its Blackwater Ready-to-Drink Platform and Longevity-Focused Nutraceutical Strategy, and Announces Strategic Share Consolidation to Advance Corporate Growth and Capital Markets Presence

News Release Highlights:Forte Group has confirmed the effective date of its previously announced corporate name change to Vanta Holdings Inc. ("VANTA") and approved a strategic 10-for-1 share consolidation, both to take effect at the start of trading on January 13, 2026, advancing the Company's corporate growth strategy and capital markets positioning.The transition to the VANTA identity unifies the Company's Blackwater ready-to-drink platform and longevity-focused nutraceutical portfolio under a single, modernized brand, aligning the parent company and its consumer-facing product ecosystem and supporting scalable commercialization across Canadian, U.S., and international markets.The share consolidation is intended to enhance the marketability of the Company's common shares, improve investor accessibility, and provide flexibility to support future corporate initiatives and financing activities, while aligning the Company's capital structure with its long-term operational and growth objectives.

Wellgistics Health Provides 2026 Corporate Outlook

Integration of prescription drug dispensing optimization aritifical intelligence platform EinsteinRx™ into pharmacy client point-of-sales systems has commencedEinsteinRx integration streamlining effort focuses on reducing onboarding process friction and speeding time to implementation prior to scaling pharmacy marketing effortCompany expects to onboard up to 500 pharmacies per month into formal Wellgistics Pharmacy Network by year end 2026Manufacturer supplier relationship expansion effort focused on diabetes, weight loss, cardiometabolic & Long COVID patients that existing pharmacy clients already servePharmacyChain™ blockchain-enabled healthcare smart contract development resource assessment ongoing

Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026

NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, CA. The Company will also participate in one-on-one meetings.

Nepra Foods Appoints Cotter Stern as Director of Ingredient Sales

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 7, 2026 / Nepra Foods Inc. (CSE:NPRA)(FSE:2P6)(OTCQB:NPRFF), a leader in specialty ingredients and allergen-free products, today announced the appointment of Cotter Stern as Director of Ingredient Sales. With over 15 years of experience in organic food trading, Mr. Stern brings deep technical understanding of global commodity markets and a proven track record of building sustainable supply chains. Mr. Stern's esteemed reputation will accelerate Nepra Foods' growth trajectory.

AMC Health Announces Breakthrough in AI-Driven Alert Precision for Virtual Care Program

New data science-driven alert framework expected to reduce clinician burden by 45% while preserving industry-leading outcomes, critical amid workforce shortages and rural care challenges

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14th, 2026, at 2:15 pm PT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.

Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension

Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of [⁶⁸Ga]Ga-PentixaFor in treatment-resistant hypertension and Primary AldosteronismType B pre-IND meeting provided non-binding guidance on key statistical and methodological aspects, enabling refinement of the Phase 3 study designFeedback clarifies evidence requirements relevant to a potential approval pathway, supporting the planned IND submission for the company's leading CXCR4-directed flagship program

CellRight Tech: Private Equity Funding Secured

SAN ANTONIO, TX / ACCESS Newswire / January 7, 2026 / CellRight Technologies, LLC, a specialist in regenerative allografts for patient implants, announces that it has secured private equity funding from Harwood Capital through its parent company, Tissue Regenix Group plc (TRG) to support commercial growth plans for the business.

WELT Unveils the World's First "AI-Combo Drug" at CES 2026

Turning Any Medication into a Precision AI-Combo Drug through Simple QR-Code Integration

Maduro lawyer previously defended WikiLeaks' Julian Assange

The lawyer defending deposed Venezuelan leader Nicolas Maduro is a veteran trial attorney who previously represented WikiLeaks founder Julian Assange.

Swiss officials admit inspections failure at inferno bar

Swiss authorities admitted Tuesday that fire safety inspections had not been carried out for the past five years at a bar where 40 people died in a New Year blaze.

Last 'holy door' at St Peter's closes to end Catholic jubilee year

Pope Leo XIV closed the final "Holy Door" in St Peter's Basilica in Rome on Tuesday, the day of Epiphany, signalling the end of the 2025 Jubilee year that drew millions of pilgrims to the city.

US Justice Dept says millions of Epstein files still not released

The US Department of Justice said Monday it is still reviewing more than two million documents potentially related to convicted sex offender Jeffrey Epstein as it pushed more than two weeks past a deadline to release all files connected to him.

Landmines destroy limbs and lives on Bangladesh-Myanmar border

In the dense hill forests along Bangladesh's border with war-torn Myanmar, villagers are losing limbs to landmines, casualties of a conflict not of their making.

Australian PM to tour outback flood disaster zone

Swollen rivers have cut off towns and swept away thousands of livestock in outback Australia, authorities said as Prime Minister Anthony Albanese flew into the disaster zone on Tuesday.

RF Industries to Report Fourth Quarter and Fiscal Year 2025 Financial Results on January 14

SAN DIEGO, CA / ACCESS Newswire / January 6, 2026 / RF Industries, Ltd, (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced that it will release its fourth quarter and fiscal year 2025 financial results after the close of the market on Wednesday, January 14, 2026.

Havertys Furniture Announces Participation in the 2026 ICR Conference

ATLANTA, GA / ACCESS Newswire / January 6, 2026 / HAVERTY FURNITURE COMPANIES, INC. (NYSE:HVT and HVT.A) announced today that Steven G. Burdette, President and CEO, and Richard B. Hare, Executive Vice President and CFO, will participate in the 2026 ICR Conference on Monday, January 12, and Tuesday, January 13, 2026. To schedule a meeting, please contact your conference representative.

ALST Signs Non-Disclosure Agreement with Major Toronto University for Proposed Allstar Sports Centre Development

TORONTO, ON / ACCESS Newswire / January 6, 2026 / ALST is pleased to announce the signing of a Non-Disclosure Agreement (NDA) with a large, internationally recognized university located in Toronto, Ontario, to explore the potential development of an Allstar Sports Centre on approximately 8 acres of land.

Former Wall Street Tech Executive Roni McGuire Launches the 2026 Motifesting Journal to Help High Achievers Manifest with Intention and Alignment

Available Now on Amazon | Official Launch January 6, 2026

Arizona Tribune - Boulevard (English)